top of page
Working at home

Emma Watson Invests in Hertility, Helping to Revolutionise Reproductive Healthcare




In a significant move to support women’s health, actress and activist Emma Watson has announced her investment in Hertility, a cutting-edge company reshaping the future of reproductive healthcare.


Hertility offers an end-to-end clinical service that spans from menstruation to menopause, providing testing, diagnosis, and treatment through its proprietary diagnostic algorithm. The technology, which is patent-pending, has been developed using the largest dataset of female gynaecological pathologies.


Deirdre O'Neill, Co-Founder and Chief Commercial & Legal Officer at Hertility, shared her excitement over the new partnership on LinkedIn, referencing a long-standing joke between herself and her co-founder that captures the team's vision. “Wingardium labiosa,” she said, playfully referencing the famous spell from Harry Potter. “This is a pun that Dr. Helen O'Neill and I joked about years ago when we were thinking about who our DREAM ambassador would be. Suffice to say, it shouldn’t require magic to know that investing in women’s health is investing in global health.”


The investment from Watson - known for her advocacy of gender equality and women’s rights - brings increased attention to the importance of reproductive health. Hertility’s innovative approach to healthcare promises to offer women better access to diagnostic services and personalised treatment, a mission aligned with Watson’s activism.


Hertility’s mission is clear: to revolutionise the entire reproductive and hormonal healthcare landscape. From menstrual disorders to fertility treatments and menopausal care, the company’s technology and medical expertise are poised to benefit women worldwide.


This investment marks a pivotal moment in the company’s journey, as they aim to expand their services and continue building a future where reproductive healthcare is both accessible and personalised for women of all ages.


Watson’s involvement brings both star power and a renewed focus on the importance of women’s health - a timely reminder that investing in reproductive health is investing in a healthier, more equitable world.

5 views0 comments

Comentarios


bottom of page